May 05, 2022 / 08:30PM GMT
Operator
Good day, ladies and gentlemen, and welcome to the Eiger BioPharmaceuticals' First Quarter 2022 Financial Results and Business Update Conference Call. (Operator Instructions) As a reminder, this call will be recorded.
I would now like to introduce Sarah Mathieson, Senior Vice President of Corporate Affairs at Eiger. You may begin.
Sarah Mathieson - Eiger BioPharmaceuticals, Inc. - SVP, Corporate Affairs
Thank you. Good afternoon, everyone, and thank you for joining us today. Welcome to our quarterly financial results and business update call. We issued a press release earlier this afternoon with our Q1 financial results, which is also available on our website at eigerbio.com.
For today's call, we will have prepared remarks from the management team followed by Q&A. We will use slides for the webcast, and a replay will be available on the Investors section of our website. Joining me on the phone with prepared remarks are David Cory, President and CEO; Sri Ryali, Chief Financial Officer; Eldon Mayer, Chief Commercial Officer; and Dr. Ingrid
Q1 2022 Eiger BioPharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot